N-[2-[[(3R)-1-[4-Hydroxy-4-(6-Methoxypyridin-3-Yl)Cyclohexyl]Pyrrolidin-3-Yl]Amino]-2-Oxoethyl]-3-(Trifluoromethyl)Benzamide N-[2-[[(3R)-1-[4-羟基-4-(6-甲氧基吡啶-3-基)环己基]吡咯烷-3-基]氨基]-2-氧乙基]-3-(三氟甲基)苯甲酰胺
CAS 887401-92-5 MFCD87401925
信息真实价格透明
资金保障
专业采购外包团队在线服务
信息真实价格透明
资金保障
专业采购外包团队在线服务
品牌质保精细包装
现货库存
一流品牌服务
相关文献及参考
- [2]. McMillin M, et al. Neuronal CCL2 is upregulated during hepatic encephalopathy and contributes to microglia activation and neurological decline. J Neuroinflammation. 2014 Jul 10;11:121.
- [1]. Xue CB, et al. Discovery of INCB3284, a Potent, Selective, and Orally Bioavailable hCCR2 Antagonist. ACS Med Chem Lett. 2011 Mar 31;2(6):450-4.
- [1]. Xue CB, et al. Discovery of INCB3284, a Potent, Selective, and Orally Bioavailable hCCR2 Antagonist. ACS Med Chem Lett. 2011 Mar 31;2(6):450-4.
- [2]. McMillin M, et al. Neuronal CCL2 is upregulated during hepatic encephalopathy and contributes to microglia activation and neurological decline. J Neuroinflammation. 2014 Jul 10;11:121.
